Anavex Life Sciences Corp expected to post a loss of 8 cents a share - Earnings Preview
Anavex Life Sciences Corp <AVXL.OQ> expected to post a loss of 8 cents a share - Earnings Preview
Anavex Life Sciences Corp AVXL.OQ AVXL.O is expected to show no change in quarterly revenue when it reports results on August 10 (estimated) for the period ending June 30 2026
LSEG's mean analyst estimate for Anavex Life Sciences Corp is for a loss of 8 cents per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts had risen by about 6.7% in the last three months.
Wall Street's median 12-month price target for Anavex Life Sciences Corp is $20.00, about 509.8% above its last closing price of $3.28
This summary was machine generated August 7 at 15:41 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Anavex Life Sciences
See all newsBrief: Anavex Provides Corporate Update, Announces Completion Of Clinical Conduct Of Adme And Ddi Clinical Studies
Brief: Anavex Receives FDA Clearance Of Its Ind Application For Blarcamesine In Fragile X Syndrome
Brief: Glass Lewis Recommends Anavex Stockholders To Vote For PVG’s Director Nominees
Brief: PVG Calls For Replacing Anavex Board, Hiring "Experienced" CEO
Brief: Pvg Asset Management- Nominates Six Director Candidates For Anavex Board